1255206-67-7

Basic information

• Product Name: 5-bromo-4-methylisobenzofuran-1(3H)-one
• Synonyms: 5-bromo-4-methylisobenzofuran-1(3H)-one;5-Bromo-4-methyl-3H-isobenzofuran-1-one
• CAS NO: 1255206-67-7
• Molecular Formula: C₉H₇BrO₂
• Molecular Weight: 227.05468
• Mol File: 1255206-67-7.mol
• Article Data: 31

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-bromo-4-methylisobenzofuran-1(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-4-methylisobenzofuran-1(3H)-one(1255206-67-7)
• EPA Substance Registry System: 5-bromo-4-methylisobenzofuran-1(3H)-one(1255206-67-7)

Safety Data

• Hazardous Substances Data: 1255206-67-7(Hazardous Substances Data)

Upstream product

• 5613-26-3 4-bromo-2,3-dimethylbenzoic acid 
• 83647-43-2 3-bromo-2-methylbenzyl alcohol 
• 1548296-37-2 4-methyl-5-(trimethylstannyl)isobenzofuran-1(3H)-one 
• 1255206-73-5 trifluoromethanesulfonic acid 4-methyl-1-oxo-1,3-dihydro-isobenzofuran-5-yl ester 
• 1194700-73-6 5-hydroxy-4-methyl-3H-isobenzofuran-1-one 
• 1255206-72-4 6-bromo-3-hydroxy-2-methylbenzenemethanol 
• 603-80-5 3-hydroxy 2-methylbenzoic acid 
• 54874-26-9 3-hydroxymethyl-2-methylphenol 
• 76006-33-2 3-bromo-2-methylbenzoic acid 
• 201230-82-2 carbon monoxide 

Downstream Products

• 1255206-69-9 5-ethenyl-4-methyl-2-benzofuran-1(3H)-one 
• 1255206-70-2 4-methyl-5-[2R-oxiran-2-yl]-2-benzofuran-1(3H)-one 

Relevant articles and documents

KRAS G12C INHIBITORS

The present invention provides compounds of the formula: where R1, R2, R3, R4, R5, A, B, and Y are as described herein, pharmaceutically acceptable salts thereof, and methods of using these compounds and salts for treating patients for cancer.

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula (I) and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylax

INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL

The present invention provides compounds of Formula I and the pharmaceutically acceptable salts thereof, which are inhibitors of the ROMK (Kir1.1) channel. The compounds may be used as diuretic and/or natriuretic agents and for the therapy and prophylaxis of medical conditions including cardiovascular diseases such as hypertension, heart failure and chronic kidney disease and conditions associated with excessive salt and water retention.